September 26th, 2013
Scrutinizing the PRAMI Trial of “Preventive Angioplasty”
Victor Montori, MD, MSc
Victor Montori offers his analysis of the PRAMI trial and the many ramifications of stopping an investigation early.
September 23rd, 2013
Selections from Richard Lehman’s Literature Review: September 23rd
Richard Lehman, BM, BCh, MRCGP
This week’s topics include a randomized trial of preventive angioplasty in MI, aliskiren in patients with prehypertension, and otamixaban and ischemic events in NSTE-ACS.
March 14th, 2012
Angioplasty Pioneer Geoffrey Hartzler Dead at 65
Larry Husten, PHD
Geoffrey Hartzler, a key figure in the development of interventional cardiology in the United States, has died from cancer at the age of 65. He was one of the first cardiologists to learn the technique of percutaneous transluminal coronary angioplasty (PTCA) from its founder, Andreas Gruentzig. Hartzler then went on to perform the first angioplasty […]
NEJM Journal Watch — Recent Cardiology Articles- To Lower Stroke Risk in Patients Undergoing Atrial Fibrillation Ablation, Is a Device or a Medication Better?
- Intensive vs. Standard Blood Pressure Lowering in Patients with Diabetes
- Anticoagulation in Patients with Cancer-Associated Pulmonary Embolism: How Long is Long Enough?
- Spironolactone Use After Percutaneous Intervention for Acute Myocardial Infarction
- CRISPR/Cas9 Gene Editing for Transthyretin Cardiomyopathy